Videos

The division chief of stroke and vascular neurology at Duke Health provided perspective on the multidisciplinary team needed to treat neuromuscular poststroke symptoms, as well as exciting innovations on the horizon. [WATCH TIME: 4 minutes]

Expanding the Capabilities of Treating Neuromuscular Poststroke Symptoms: Wayne Feng, MD, FAHA

, has been with the team since October 2019. Follow him on Twitter 

Articles

Treatment with the investigational agent resulted in improvements in Alzheimer disease agitation, as well as significant delays in time to relapse and prevention of relapse.

AXS-05 Meets Primary End Point in Phase 3 Trial of Alzheimer Agitation

, has been with the team since September 2022. Follow her on Twitter 

A recent cross-sectional analysis showed an increase in coded diagnoses of insomnia during pregnancy in the United States over time.

Insomnia Diagnosis During Pregnancy Increased in the United States, Analysis Shows

The professor of medicine at the University of Manitoba provided insight on a recently published paper which challenges the way multiple sclerosis is categorized and treated. [WATCH TIME: 5 minutes]

Changing the Way Multiple Sclerosis Disease Progression is Perceived: Ruth Ann Marrie, MD, PhD, FRCPC

The relative risk of epilepsy or seizures after COVID-19 infection, compared with influenza infection, was more marked amongst children and non-hospitalized individuals over the 6-month time horizon.

Although Increased, Risk of Epilepsy and Seizures Following COVID-19 Remain Low

The president of the International Neuropalliative Care Society detailed potential disease states that could benefit from neuropalliative care as well as the importance of the patient community in expanding this type of approach. [WATCH TIME: 4 minutes]

Expanding Neuropalliative Care to New Disease States: Benzi Kluger, MD, MS

Here's some of what is coming soon to NeurologyLive® this week.

This Week on NeurologyLive® — November 28, 2022

, has covered medical news for MJH Life Sciences, 

’s parent company, since 2017. He hosts the 

Experts in neurology discuss changes in cognitive health and the role that sphingosine-1-phospate receptor modulators and disease-modifying therapies play in MS management.

Prioritizing Cognition and Adapting to Novel Therapeutics in Multiple Sclerosis

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.

NeurologyLive® Brain Games: November 27, 2022

Bruce Cree, MD, PhD, MAS, FAAN, offered his perspective on data from the phase 2/3 N-MOmentum trial of the recently approved inebilizumab (Uplizna; Horizon Therapeutics) and why the therapy stands out from other NMOSD treatments.

All News

Latest News